|
Check Us Out Now!! We Are Hot!! CVAT,VSYM,SGCA,HYGS,ALXN,THQ:: Sign Up Now!!
(M2 PressWIRE Via Acquire Media NewsEdge) STOCK MARKETING INC PRESENTS : (OTCBB: CVAT) Cavitation Technologies, Inc., (OTCBB: VSYM) View Systems, Inc., (OTCBB: SGCA) Strategic American Oil Corp., (NASDAQ: HYGS) Hydrogenics Corp., (NASDAQ: ALXN) Alexion Pharmaceuticals, Inc., (NASDAQ: THQI) THQ, Inc.
www.StockMarketingInc.com
To sign up for our free Profiles & Alerts :: visit http://www.StockMarketingInc.com
email us!! info@StockMarketingInc.com or call 1-866-583-8960
---------------------------
(OTCBB: CVAT - Cavitation Technologies, Inc.)
LATEST NEWS!!
CaviGulation - Cavitation Technologies' Solution to the Water Crisis, Refining the Desalination Process
LOS ANGELES, Dec 01, 2009 -- Cavitation Technologies, Inc. (CTI) (OTC Bulletin Board: CVAT; Berlin: WTC) is announcing our latest development the CaviGulation system, designed for physico-chemical reactions used in water treatment. With water well on its way to becoming one of the hottest commodities, an obvious solution is to take the salt out of seawater. Desalination technology has been around for thousands of years. However, until recently seawater desalination was a very expensive water source solution, we believe we have the answer. On average there is roughly 130 grams of salt per gallon in sea water. Desalination can reduce salt levels to below 2 grams per gallon, which is the limit for safe human consumption.
CaviGulation is a complex process with a multitude of mechanisms operating synergistically to remove pollutants from the water. The CaviGulation reactor is a multi stage flow-through electro-cavitation process on the nano molecular level. The effectiveness of CG technology is 1000-fold over conventional systems and allows the complete elimination of all micro-organisms (including spores), viruses and protozoa. The first actual practice of desalination involved collecting the freshwater steam from boiling saltwater. The energy required for this type of process today makes it prohibitively expensive on a large scale. In the last decade, seawater reverse-osmosis has matured into a viable alternative to thermal desalination. But even with membranes, large amounts of energy are required to generate the high pressure that forces the water through the filter. Maintenance costs, addition of additives to prevent periodic buildup and replacement of the fouling membranes are the biggest challenge facing desalination. To produce 1,000 gallons of desalinated seawater it can cost around $4. Our goal is to cut this cost in half. CaviGulation is CTI's proprietary process and is scalable to virtually any size; we feel it could be a solution for the desalination process utilizing membranes. Currently, between 10 and 13 billion gallons of water are desalinated worldwide per day. That's only about 0.2 percent of global water consumption, but the number is drastically increasing, the demand is rising and the problem needs immediate attention on a large scale while being cost effective at the same time.
For additional information please paste the following link: www.cavitationtechnologies.com/component/option,com_phocadownload/Itemid,68/id,7/view,category/ Cavitation Technologies, Inc. continues to identify new applications for our nano-reactor technology. All of the applications are in industries where there is a need to solve environmental problems, reduce operating costs and improve profitability. "After years of research CTI's scientists have developed our CaviGulation system. The first prototype unit has been built and delivered to our testing facility in Chatsworth, Ca. It will require several more months of testing in order to be able to establish all of the benefits and savings that could be provided for the desalination industry. We are exceptionally proud of the fact that the technologies we are developing will have a global impact, we strive to come up with a viable solution to the worldwide issues we face with water." indicated Roman Gordon, Cavitation Technologies, Inc., CEO.
About Cavitation Technologies Cavitation Technologies, Inc. (CTI); (OTCBB: CVAT); is a "Green-Tech" company, established in 2006 to become a world leader in the development of new cutting edge technologies for the vegetable oil refining, renewable fuel, petroleum, water treatment, wastewater sanitation, food and beverage, and chemical industries. For additional information please visit: www.cavitationtechnologies.com
---------------------------
(OTCBB: VSYM - View Systems, Inc.)
LATEST NEWS!!
View Systems' Announces Confirmation of Additional ViewScan Order from Belcom
BALTIMORE, Dec 01, 2009 -- View Systems, Inc. (OTC Bulletin Board: VSYM), a security and tele-data solutions provider, confirmed today that Belcom, View's leading international authorized dealer and business partner, has doubled their original 40-unit order, making it an order for 80 units.
ViewScan is fast becoming the choice screening system, both domestically and internationally. It's a computer-based system that can scan up to 1200 people per hour. As a person passes through the portal, a photograph is taken and stored on the laptop computer that comes with the unit. Threat objects are visually located on the computer screen and an audible alert can be set to sound. The ViewScan produces no harmful emissions so it's safe for everyone.
Belcom is an authorized and exclusive international dealer and business partner of View Systems. Belcom represents View Systems' products in the Middle East, Africa, Saudi Arabia, Kuwait, Qatar, Bahrain, UAE, Oman, Jordan, Iraq, India, Pakistan, Bangladesh and Yemen. Belcom is a subsidiary of the Belhasa Group of Companies, a trusted security and services firm with proven performance throughout the Middle East and Africa. Belcom is one of the fastest growing security services companies in the Middle East today. Belcom's corporate headquarters is based in Dubai, UAE with field offices located throughout the MENA region. (Source: www.belcom.ae). Belcom's team has an impressive track record of successfully completing projects for clients regardless of location, specifically with ViewScan units currently placed in Saudi Arabia, Bahrain, UAE, India and Pakistan.
"This confirmed order for 40 additional units is an ongoing testimony to the reliability and performance of the ViewScan," states Gunther Than, View Systems' CEO. "We have a signed contract in hand and are acquiring the parts necessary to complete a build of 100 units. We expect to start shipping to Belcom before the 2009 year end. We have received indications that additional substantial orders are forthcoming." About View Systems: View Systems, Inc. manufactures and installs weapons detection identification systems, video management platforms and tele-data communication networks targeted towards correctional facilities, schools, courthouses, government agencies, event and sports venues, and commercial businesses. More information can be found on the website at www.viewsystems.com.
---------------------------
(OTCBB: SGCA - Strategic American Oil Corp.)
LATEST NEWS!!
Strategic American Oil Corporation Appoints Jeremy Driver as President and Chief Executive Officer
CORPUS CHRISTI, Texas, Dec 01, 2009 -- Strategic American Oil Corporation (OTC Bulletin Board: SGCA) (the "Company") is pleased to announce it has appointed Jeremy Driver as the new President and Chief Executive Officer of the Company, effective December 1st, 2009. Mr. Driver succeeds Randall Reneau, who will continue to serve as Chairman of the Board of Directors.
With a solid background in upstream oil and gas, specifically in Texas and Louisiana, Mr. Driver brings proven experience, leadership, and professional skills to a growing company. Most recently, he served as President of HYD Resources Corporation (wholly-owned subsidiary of publicly traded firm - Hyperdynamics Corporation, an operating oil and gas company headquartered in Houston, TX. Mr. Driver led the turn-around of HYD Resources ultimately bringing it to profitability and later focusing on strategic acquisitions to increase acreage, reserves, and daily production.
Prior to his tenure at HYD Resources, Mr. Driver served honorably with the United States Air Force as an Officer, Chinese Linguist, and foreign intelligence specialist. He holds a Master of Business Administration degree as well as a Master of Science in Accounting degree from Northeastern University and while serving in the military he earned his B.S. in Liberal Studies, Chinese Language from Excelsior College.
Mr. Driver aims to strengthen the Company's profile with the investment community, develop merger and acquisition strategies, and further identify oil and gas development projects that meet the Company's exacting standards.
Randall Reneau, Chairman stated, "Jeremy's extensive oil and gas experience while with HYD in Houston, including projects in Texas and Louisiana, two of the Company's core operational areas, along with his strong educational background make him a valuable addition to the Strategic American team. I am also very pleased that he will be working out of the Company's Corpus Christi office where the balance of our operational staff is based. Jeremy has an excellent understanding of both the operational aspects of an oil company and the management of a public company. I am very proud to be introducing Jeremy to this Company and working with him to increase our shareholder value." "I am very excited to be joining the Strategic American Oil team," said Mr. Driver. "I believe strongly that with our impressive portfolio of prospects, our first-class team of geologists and engineers, and our solid financial positioning we are poised for remarkable growth in the very near future." About Strategic American Oil Corporation Strategic American Oil Corporation (OTCBB: SGCA) is an exploration and production company with operations in Texas, Louisiana, and Illinois. The company draws on an internationally recognized team of geologists, engineers, and executives with extensive oil and gas exploration and production experience. The Company's objective is to find and acquire oil and gas projects of merit and develop those projects to their full potential.
www.strategicamericanoil.com
---------------------------
(NASDAQ: HYGS - Hydrogenics Corp)
LATEST NEWS!!
Hydrogenics Announces New Line of Credit in Europe
Facility to Provide Capital for 2010 Expansion
MISSISSAUGA, Ontario, Dec 2, 2009 -- Hydrogenics Corporation (Nasdaq:HYGS) (TSX:HYG), a leading developer and manufacturer of hydrogen generation and fuel cell products, today announced that Hydrogenics Europe N.V., its Belgium-based operating subsidiary (the "Borrower"), has secured a EUR 3.5 million operating facility from Dexia Bank S.A., a Belgium-based financial institution. The facility will be used to finance working capital requirements for Hydrogenics' OnSite Generation business in 2010.
"This operating facility will provide increased working capital for our electrolyzer operations next year and speaks to the increased availability of attractive credit in our end markets," said Daryl Wilson, President and CEO. "The facility will allow our European operations greater flexibility to more rapidly respond to customer orders and ship equipment in a more timely manner. Given our growth plans for 2010, we felt that now was the best time to take advantage of this opportunity." Pursuant to the terms of the credit facility, the Borrower may borrow a maximum of 75% of the value of awarded sales contracts, approved by Dexia Bank, to a maximum of EUR 2.0 million, along with a maximum of EUR 1.5 million for general business purposes.
The credit facility bears interest at a rate of Euribor plus 1.45% per annum. It is secured by a EUR 1.0 million first secured charge covering all of the assets of the Borrower, which may be increased to EUR 1.5 million in certain circumstances, and contains a negative pledge precluding the Borrower from providing security over its assets. Additionally, the Borrower is required to maintain a solvency covenant, defined as equity plus current account divided by total liabilities, of not less than 25% and ensure that its inter-company account with Hydrogenics Corporation does not decrease to less than EUR 5.0 million at any time. As of November 30, 2009, the inter-company account was approximately EUR 5.1 million.
ABOUT HYDROGENICS Hydrogenics Corporation (www.hydrogenics.com) is a globally recognized developer and provider of hydrogen generation and fuel cell products and services, serving the growing industrial and clean energy markets of today and tomorrow. Based in Mississauga, Ontario, Canada, Hydrogenics has operations in North America and Europe.
---------------------------
(NASDAQ: ALXN - Alexion Pharmaceuticals, Inc.)
LATEST NEWS!!
Alexion Reports Progress on Commissioning of Rhode Island Manufacturing Facility as Second Source of Supply
CHMP Issues Positive Opinion for European Union; FDA Review Ongoing
CHESHIRE, Conn., Dec 02, 2009 -- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today provided updates on the regulatory review and approval, or commissioning, of Alexion's Rhode Island manufacturing facility (ARIMF) in Smithfield, Rhode Island as a second source of supply for Soliris(R) (eculizumab). The Company reported that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a "positive opinion" recommending final approval of the facility by the European Commission, which is expected in early 2010. Separately, the Company expects to meet with the U.S. Food and Drug Administration (FDA) to provide additional available information, and to discuss their request for a limited number of production runs in connection with their pre-approval inspection process.
Second Source of Supply Since 2006, Alexion has been developing ARIMF to become a second source of supply of Soliris and to manufacture other antibody products. The facility does not yet provide Soliris for commercial use in any market. As a result of the Company's previously described multi-source strategy, Alexion has existing supplies of Soliris sufficient to serve all anticipated clinical and commercial needs, while continuing to source product from its primary provider.
"We are pleased to receive the positive opinion from the CHMP, which would give us the option to use ARIMF as a second source to supply Soliris to European countries following final EU approval," said Stephen P. Squinto, Executive Vice President and Head of Research and Development at Alexion. "We now look forward to progressing our discussions and satisfying the requirements of the FDA, which would give us the additional option of using our Rhode Island facility as a second source to serve the U.S. market as well." Separately, the Company provided an update on a previously described regulatory review of an external vialer previously used by Alexion. Alexion reported today that regulatory authorities have now permitted release to the marketplace of all batches of Soliris that were filled by this external vialer. The previously described contingent liability associated with these batches has now been completely resolved at no loss to the Company.
About Alexion Alexion Pharmaceuticals, Inc. is a biopharmaceutical company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions. Alexion is engaged in the discovery, development and commercialization of therapeutic products aimed at treating patients with a wide array of severe disease states, including hematologic and kidney diseases, transplant, cancer, and autoimmune disorders. Soliris(R) (eculizumab), Alexion's first marketed product, is approved in the U.S., European Union, Australia and Canada as a treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH), a rare, debilitating and life-threatening blood disorder. Alexion is evaluating other potential indications for Soliris as well as other formulations of eculizumab for additional clinical indications, and is pursuing development of other antibody product candidates in early stages of development. This press release and further information about Alexion Pharmaceuticals, Inc. can be found at: www.alexionpharma.com.
---------------------------
(NASDAQ: THQI - THQ, Inc.)
LATEST NEWS!!
THQ Names Germaine Gioia Senior Vice President, Licensing and Merchandising
AGOURA HILLS, Calif., Dec 02, 2009 -- THQ Inc. (NASDAQ: THQI) today announced the appointment of video game industry veteran Germaine Gioia as senior vice president, licensing and merchandising, effective immediately.
Gioia's tenure in the video game industry spans nearly two decades. She rejoins THQ after serving as senior vice president, licensing for Capcom Entertainment in the US and European territories for the past three years. At Capcom, Gioia oversaw and secured merchandising partnerships for Capcom's franchises, spanning electronics, apparel, book and music publishing, toy, home furnishings, promotion and media. She also secured intellectual property procurement across game platforms. Gioia previously headed the licensing efforts of THQ for 14 years, where she was instrumental in securing many of THQ's most successful franchises. She returns to THQ along with Josh Austin to work with each of THQ's business units in their licensing and merchandising efforts.
"We are pleased to welcome Germaine back to THQ. She will play an integral role in both securing new intellectual properties for THQ as well as expanding the merchandising opportunities for our own brands," said Brian Farrell, president and CEO, THQ.
Germaine Gioia said, "I am excited to return to a well-positioned and highly focused THQ. Today's market offers many new opportunities for growth and I look forward to helping the THQ team build our portfolio of intellectual properties and broaden the exposure of our brands across entertainment mediums and other relevant markets." Gioia's prior roles include director of corporate communications at CIC, a high-technology computer software development company in Silicon Valley and corporate marketing communications at LucasArts Entertainment Company. Gioia holds a bachelor's degree from Vanderbilt University.
About THQ THQ Inc. (NASDAQ: THQI) is a leading worldwide developer and publisher of interactive entertainment software. The company develops its products for all popular game systems, personal computers and wireless devices. Headquartered in Los Angeles County, California, THQ sells product through its global network of offices located throughout North America, Europe and Asia Pacific. More information about THQ and its products may be found at www.thq.com. THQ and its logos are trademarks and/or registered trademarks of THQ Inc.
---------------------------
About StockMarketingInc.com
StockMarketingInc.com is a website that profiles stocks of interest. We are not licensed brokers or financial consultants. The information here is believed to be reliable, but not guaranteed to be accurate by StockMarketingInc.com. Please be advised that the information contained may or may not be complete and is solely for informational purposes only. This is not to be construed as an offer to sell, hold or the solicitation of an offer to buy. Investors are encouraged to seek opinions by their registered brokers or financial advisors after extensive due diligence is performed.
((Comments on this story may be sent to info@m2.com))
(c) 2009 M2 COMMUNICATIONS
[ InfoTech Spotlight's Homepage ]
|
